1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. AddLife AB (publ)
  6. News
  7. Summary
    ALIF B   SE0014401378


Delayed Nasdaq Stockholm  -  05/27 11:29:58 am EDT
245.60 SEK   +5.59%
05/05Annual General Meeting of AddLife AB 5 May 2022
05/05Addlife AB Approves Dividend, Payable on 12 May 2022
04/28TRANSCRIPT : AddLife AB, Q1 2022 Earnings Call, Apr 28, 2022
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

AddLife is increasing its investment in digital health by acquiring Telia Health Monitoring

12/20/2021 | 05:01am EDT

AddLife has taken another step in strengthening its position in digital health by today signing an agreement to acquire Telia Health Monitoring to add to its Medtech business area. Telia Health Monitoring develop and provides a digital platform solution that enables self-monitoring by patients with chronic diseases. The business, with sales of SEK 4m, and its eight employees, will be integrated into Camanio, which was acquired earlier in December 2021. Completion is expected to take place in the first quarter of 2022.

The acquisition of Telia Health Monitoring adds a further piece in AddLife's digital strategy and strengthens its ability to be a key stakeholder in the development of digital health and care services. Currently, the business has agreements with both private care providers and regions in Sweden. A total of around 1,000 patients are connected to the solution, which is scalable and can handle a growing number of patients and their unique needs.

The solution can currently be used for a number of chronic diseases, such as heart disease, hypertension, COPD, diabetes, IBD and is also developed for self-monitoring within specialist maternity care. By combining the digital care platform from Camanio with Telias Health Monitoring solution, several benefits are offered for individual centred care and nursing. Around 45% of people in Sweden are estimated to have at least one chronic disease, and the costs of caring for chronic patients amount to around 80% of total healthcare costs, according to the Swedish Agency for Health and Care Services Analysis. Digital tools enable continuous and more efficient care as a result of closer communication with the care provider and more personalised treatment. At the same time, they give patients a greater sense of security, freedom and quality of life in everyday life.

Kristina Willgård, CEO of AddLife, comments: "Our vision is to improve people's lives and we see a major societal challenge in the healthcare sector, with a growing and increasingly elderly population with chronic diseases. Digital care and better data support can both improve the quality of life for patients and are essential for improving the quality and efficiency of care. By combining the digital care platform from Camanio with Telia's Health Monitoring solution we have great opportunities to support care providers in the development of the digital care."

"We are delighted to have found a new home for Telia Health Monitoring at AddLife. AddLife is a specialised life science company that shares our vision of improving people's lives. It understands the value of the strong position in remote health monitoring that we have developed and maintained over a number of years. With its portfolio, entrepreneurial approach and European presence, we believe that AddLife is uniquely positioned to take this business to the next level," says Brendan Ives, Manager of Division X at Telia Company.

Stockholm, 20 December 2021
AddLife AB (publ)

For further information, please contact
Kristina Willgård, CEO, AddLife AB, +46 (0)705 10 12 23
Martin Almgren, Business Area Manager Medtech and CFO, AddLife AB, +46 (0)702 28 15 45

AddLife is an independent European player in Life Science that offers high-quality products, services and consulting to both the private and public sectors. AddLife has about 1,800 employees in around 70 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 7.5 billion. AddLife is listed on the NASDAQ Stockholm stock exchange.

This information was issued for publication on 20 December 2021 at 11:00 CET.



(c) 2021 Cision. All rights reserved., source Press Releases - English

Stocks mentioned in the article
ChangeLast1st jan.
ADDLIFE AB (PUBL) 5.59% 245.6 Delayed Quote.-35.61%
TELIA COMPANY AB -0.20% 40.61 Delayed Quote.14.70%
All news about ADDLIFE AB (PUBL)
05/05Annual General Meeting of AddLife AB 5 May 2022
05/05Addlife AB Approves Dividend, Payable on 12 May 2022
04/28TRANSCRIPT : AddLife AB, Q1 2022 Earnings Call, Apr 28, 2022
04/28Interim Report 1 January - 31 March 2022
04/28AddLife AB Reports Earnings Results for the First Quarter Ended March 31, 2022
04/21AddLife Names New President/CEO
04/21Fredrik Dalborg is appointed new President and CEO of AddLife
04/21AddLife AB Appoints Fredrik Dalborg as Chief Executive Officer
04/21AddLife AB Appoints Fredrik Dalborg as President
04/01Addlife Acquires German Life Sciences Company BioCat
More news
Sales 2022 9 317 M 947 M 947 M
Net income 2022 595 M 60,5 M 60,5 M
Net Debt 2022 4 070 M 414 M 414 M
P/E ratio 2022 50,5x
Yield 2022 0,59%
Capitalization 29 890 M 3 038 M 3 038 M
EV / Sales 2022 3,64x
EV / Sales 2023 3,47x
Nbr of Employees 2 119
Free-Float 92,6%
Duration : Period :
AddLife AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADDLIFE AB (PUBL)
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 1
Last Close Price 245,60 SEK
Average target price 310,00 SEK
Spread / Average Target 26,2%
EPS Revisions
Managers and Directors
Kristina Willgňrd Chief Executive Officer
Martin Almgren CFO & Business Area Manager-Medtech
Johan Olov Sj÷ Chairman
Morten Willemoes Dyrner Manager-Research Group
Lars Hňkan Pňvel Roos Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ADDLIFE AB (PUBL)-35.61%3 038
MODERNA, INC.-41.86%58 733
LONZA GROUP AG-24.79%44 437
IQVIA HOLDINGS INC.-21.85%41 736
SEAGEN INC.-8.54%26 026